What is the average life expectancy of lymphoma patients

Many citizens have a wrong understanding of cancer, which leads them to equate cancer with terminal illness, and lymphoma is no exception. Experts point out that "lymphoma is not a terminal illness, and advances in medical research have made lymphoma no longer a terminal illness." Generally speaking, the concept of "cure" of tumors is related to the "5-year disease-free survival rate." So what is the average life expectancy of lymphoma?

Long-term observations have found that if cancer patients have passed the fifth year of treatment smoothly, the probability of tumor recurrence is less than 10%, and they can be considered cured at this time. "Although there is still a large gap in the treatment effects of different subtypes of lymphoma, the overall efficacy has been greatly improved, and it has become one of the malignant tumors with the best treatment effect among the few curable cancers."
According to reports, the main treatments for lymphoma include immunotherapy, chemotherapy, radiotherapy, and hematopoietic stem cell transplantation. At present, chemotherapy is still the first choice for most lymphoma patients. Experts point out that if 3 to 5 chemical drugs are used at the same time, the 5-year survival rate of Hodgkin's lymphoma patients can be increased to 70% to 80%; the 5-year survival rate of non-Hodgkin's lymphoma patients can be increased to 40% to 50%. Radiotherapy can eliminate huge tumors in the body and residual tumors after chemotherapy.
"Among them, immunochemotherapy is currently the first-line treatment option preferred by the medical community." A large amount of clinical research data shows that 50% to 60% of patients with early lymphoma can be cured during initial treatment using immunochemotherapy regimens represented by monoclonal antibody rituximab.